AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial

Axsome Therapeutics announced topline trial results, which show AXS-12 significantly improves key narcolepsy symptoms.

Related Keywords

,Michael Thorpy ,Herriot Tabuteau ,Albert Einstein College Of Medicine ,Montefiore Medical Center ,Wake Disorders Center ,Axsome Therapeutics ,Axsome Therapeutic ,Clinician Global Impression ,Narcolepsy Symptom Assessment ,Epworth Sleepiness Scale ,Cognitive Function Items ,Functional Outcomes ,Sleep Questionnaire ,Sleep Wake Disorders Center ,Albert Einstein College ,